Deficiencies of the GPI-anchored complement regulatory proteins CD55 and CD59 on these hematopoietic cells lead to uncontrolled terminal complement activation and intravascular hemolysis, which is the primary clinical manifestation of PNH and one of the main causes of thrombosis [3,10]. This evidence concerns the gene CD59 and paroxysmal nocturnal hemoglobinuria.